DOJ Filing Challenges cannabis rescheduling
MMJ International rejects DOJ filing on cannabis rescheduling, saying it undercuts FDA approvals, workplace drug testing and compliant clinical trials.
Tag: DOJ
DOJ Order Leaves tribal cannabis Programs Out
DOJ moved FDA-approved medical cannabis to Schedule III but omitted tribal cannabis programs, leaving questions on DEA registration, supply and tax policy.
DOJ Considers Ending Firearm Ban for Marijuana Users
The U.S. Department of Justice (DOJ) is reevaluating the federal prohibition on firearm possession for individuals who use marijuana. This…